All News about Travere Therapeutics Inc
The Latest Analyst Ratings for Travere Therapeutics
April 17, 2023
Via Benzinga
Via GlobeNewswire
Travere Therapeutics's Return On Capital Employed Overview
February 28, 2023
Via Benzinga
Via GlobeNewswire
Via GlobeNewswire
Travere Therapeutics's Earnings Outlook
February 22, 2023
Via Benzinga
What 10 Analyst Ratings Have To Say About Travere Therapeutics
February 22, 2023
Via Benzinga
Via Benzinga
Travere Therapeutics Announces Proposed Public Offering of Common Stock
February 27, 2023
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 21, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
February 21, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 20, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free